ETH
ENGNW icon

Exos TFP Holdings’s enGene Therapeutics Warrants ENGNW Stock Holding History

Exos TFP Holdings’s Portfolio ENGNW Stock Details ENGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$30.2K Buy
+35,491
New +$27.3K 0.02% 100

Other funds holding ENGNW

FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Exos TFP Holdings's ENGNW Position: Q4 2023 in Review

Exos TFP Holdings opened a new position in enGene Therapeutics Warrants (ENGNW) in Q4 2023: 35,491 shares worth $30.2K. The stake represents 0.02% of the portfolio and ranks #100 among its holdings.

24 funds tracked by Wall St. Rank hold ENGNW as of Q4 2023.

  • Exos TFP Holdings held 35,491 shares of enGene Therapeutics Warrants worth $30.2K as of Q4 2023.
  • enGene Therapeutics Warrants was a new Exos TFP Holdings position in Q4 2023.
  • enGene Therapeutics Warrants made up 0.02% of Exos TFP Holdings's portfolio in Q4 2023, its #100 holding.
  • 24 funds tracked by Wall St. Rank held enGene Therapeutics Warrants as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.